We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rare Plant Stops Tumor Growth in Lab

By Biotechdaily staff writers
Posted on 10 Feb 2005
A compound derived from a rare South American plant has shown the ability to stop the growth of human breast cancer cells in laboratory cultures.

The compound, called SL0101, comes from a plant called Forsteronia refracta, a member of the dogbane family found in the Amazon rain forest. The compound works like a key in a molecular lock. It inhibits the action of a cancer-linked protein called RSK, which the researchers discovered is important for controlling the growth of breast cancer cells. However, SL0101 does not alter the growth of normal breast cells.

"By preventing RSK from working, we completely stopped the growth of breast cancer cells but did not affect the growth of normal breast cells,” said Deborah Lannigan, assistant professor of microbiology at the University of Virginia Cancer Center (Charlottesville, USA). Dr. Lannigan and Jeffrey Smith, a research assistant professor of pathology at the center, have begun testing the compound in animal models. Their work was reported in the February 1, 2005, issue of Cancer Research.

"We will modify the structure of SL0101, if necessary, to eventually find a compound that can be carried through to human clinical trials,” said Dr. Smith. "But human trials will likely be years down the road.”





Related Links:
U. of Virginia Cancer Center

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Aspiration System
VACUSAFE
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
All-in-One Molecular System
AIO M160

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
10 Feb 2005  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
10 Feb 2005  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
10 Feb 2005  |   BioResearch